BioMed Research International

BioMed Research International / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 8503426 | 9 pages |

Phytochemical, Antimicrobial, and Toxicological Evaluation of Traditional Herbs Used to Treat Sore Throat

Academic Editor: Jane Hanrahan
Received28 Dec 2015
Revised04 Apr 2016
Accepted17 Apr 2016
Published26 Jun 2016


The in vitro antibacterial activities of 29 traditional medicinal plants used in respiratory ailments were assessed on multidrug resistant Gram-positive and Gram-negative bacteria isolated from the sore throat patients and two reference strains. The methanolic, n-hexane, and aqueous extracts were screened by the agar well diffusion assay. Bioactive fractions of effective extracts were identified on TLC coupled with bioautography, while their toxicity was determined using haemolytic assay against human erythrocytes. Qualitative and quantitative phytochemical analysis of effective extracts was also performed. Methanolic extract of 18 plants showed antimicrobial activity against test strains. Adhatoda vasica (ZI = 17–21 mm, MIC: 7.12–62.5 μg/mL), Althaea officinalis (ZI = 16–20 mm, MIC: 15.62–31.25 μg/mL), Cordia latifolia (ZI = 16–20 mm, MIC: 12.62–62.5 μg/mL), Origanum vulgare (ZI = 20–22 mm, MIC: 3–15.62 μg/mL), Thymus vulgaris (ZI = 21–25 mm, MIC: 7.81–31.25 μg/mL), and Ziziphus jujuba (ZI = 14–20 mm, MIC: 7.81–31.25 μg/mL) showed significant antibacterial activity. Alkaloid fractions of Adhatoda vasica, Cordia latifolia, and Origanum vulgare and flavonoid fraction of the Althaea officinalis, Origanum vulgare, Thymus Vulgaris, and Ziziphus jujuba exhibited antimicrobial activity. Effective plant extracts show 0.93–0.7% erythrocyte haemolysis. The results obtained from this study provide a scientific rationale for the traditional use of these herbs and laid the basis for future studies to explore novel antimicrobial compounds.

1. Introduction

Infectious diseases are a major cause of death and disability in humans as they are responsible for about 22% of the disease burden globally [1]. Sore throat is the most prevalent illness known to mankind. It has been reported that almost 25% of population experienced 2-3 episodes of infection every year [2]. Staphylococcus aureus (S. aureus) is an opportunistic pathogen carried asymptomatically on the human body, mainly the anterior nares and throat [3]. Carriage of S. aureus plays a key role in the epidemiology and pathogenesis of infection and is associated with an increased risk of infectious complications after surgery in patients, intravascular devices, and superinfections [4]. Approximately 80% of invasive nosocomial infections are caused by strains of endogenous origin of nasal and throat [5, 6]. Antibiotics have saved lives of millions of people and contributed to improving quality and expectancy of life over the last century [7]. Since the discovery of penicillin in 1940s, antibiotics have been the best choice for the treatment of infectious diseases. However, the clinical efficacy of many presently used antibiotics is being threatened by the emergence of multidrug resistant (MDR) pathogens, as well as the use and misuse of existing antibiotics in humans, animals, and agriculture [8]. Several other factors like poverty, overcrowding, and lack of education all make this wonderful weapon useless. A number of multidrug resistant bacteria are increasingly observed in the normal community and hospital setting [9]. Methicillin-resistant S. aureus (MRSA) strains have acquired a gene that makes them resistant to all beta-lactam antibiotics. It is estimated that more people have died of MRSA infection than of other life threating diseases like HIV/AIDS and tuberculosis [10]. Hence, search for novel antimicrobial compounds or alternative therapy for these resistant infectious agents is inevitable.

Traditional herbal medicines have received much attention as a source of novel antibacterial drugs since they are considered as safe for human use [11]. Plant based medicines are widely used for primary health care in many developing countries [12]. As a result, it is found that about 60–80% of the world population relies on traditional treatment [13]. Plants have also been explored to get crude natural extracts for testing and developing potent and new antimicrobial drugs. A large number of secondary metabolites such as alkaloids, tannins, and flavonoids extracted from different medicinal plants have shown antimicrobial potential [14]. This finding has raised hope of obtaining novel antibiotics that can aid in fighting against multiple drug resistant bacteria [15].

For tracking and characterization of the active components thin layer chromatography (TLC) coupled with direct bioautography has gained the popularity as an effective technique [16]. Although TLC has a lower separation power than HPLC and GC, it offers several benefits such as limited samples preparation and ability to run many samples in parallel [17]. It has been proven to be effective, time-saving, and economical tool for bioassay-guided isolation of antibacterial components [18].

For the use of these herbs or their active part in human consumption, their safety towards human must be evaluated. Plants may contain such compounds that may have haemolytic or antihaemolytic effect on human erythrocytes. Therefore, many of the traditional plants need to be evaluated for their potential haemolytic activity to be categorised as a safer remedy to cure diseases.

The aims of the present study were (i) to screen the selected traditional herbs, chosen for the fact that they have been used in treating respiratory ailments or their symptoms, for potential antibacterial activity, (ii) to isolate active fraction(s), showing antibacterial activity by TLC direct bioautography, (iii) to carry out qualitative and quantitative phytochemical studies on active fractions, and (iv) to do toxicity analysis by determining the haemolysis percentage of the extract against human blood cells.

2. Experimental

2.1. Preparation of Plant Extract and Antimicrobial Efficacy

The fresh plant materials of selected plant (Table 1) were dried in open air protected from direct exposure to sunlight. Dried plant materials were separately powdered and extracted with 95% methanol or n-hexane using Soxhlet method, while aqueous extracts were prepared by soaking plant material in deionized water for 02-03 hours at 70°C. The extract so obtained was concentrated on rotary evaporator. The resulting material was dried to maximum possible level in freeze dryer and stored in glass vials at 4°C until used. For antimicrobial testing, 100 mg of the dry residue was dissolved in respective solvents or DMSO and evaluated through well diffusion assay against the six clinical and standard strains. Zone of inhibition was measured in mm and the breakpoint for susceptibility was taken as zone of inhibition >11 mm. Vancomycin and gentamicin were used as positive control, while DMSO was employed as a negative control.

Serial numberPlant name Family nameCommon namePart of plant usedVoucher number

1Adhatoda vasica (L.)AcanthaceaeNeesLeavesZD-IM-01
2Aloe vera (L.)XanthorrhoeaceaeAlovera LeavesZD-IM-02
3Althaea officinalis (L.)MalvaceaeMarshmallowFlowers, leavesZD-IM-03
4Cinnamomum zeylanicum (L.)LauraceaeCinnamonBark ZD-IM-04
5Cordia latifolia (Roxb.)BoraginaceaeSapistan, lasoriFruitsZD-IM-05
6Emblica officinalis (Gaertn.)EuphorbiaceaeIndian gooseberryFruits ZD-IM-06
7Eugenia caryophyllata (L.)MyrtaceaeCloveFruitZD-IM-07
8Glycyrrhiza glabra (L.)LeguminosaeLiquoriceRootsZD-IM-08
9Hyssopus officinalis (L.)LamiaceaeHyssopLeaves, flowersZD-IM-09
10Lawsonia inermis (L.)LythraceaeHennaLeavesZD-IM-10
11Linum usitatissimum (L.)LinaceaeFlax seedSeedZD-IM-11
12Malva sylvestris (L.)MalvaceaeMallowFlowersZD-IM-12
13Matricaria chamomilla (L.)AsteraceaeChamomileFlowers ZD-IM-13
14Mentha piperita (L.)LamiaceaeMintLeavesZD-IM-14
15Moringa oleifera (Lam.)Moringaceae Moringa, drumstick treeLeavesZD-IM-15
16Morus alba (L.)MoraceaeWhite mulberryFruits, leavesZD-IM-16
17Ocimum basilicum (L.)LabiataeBasilLeaves ZD-IM-17
18Onosma bracteatum (L.)Boraginaceae Gao zuban Leaves, flowersZD-IM-18
19Origanum vulgare (L.)LabiataeOregano Leaves ZD-IM-19
20Pimpinella anisum (L.)UmbelliferaeAniseFruit ZD-IM-20
21Piper longum (L.)PiperaceaeLong pepperFruit ZD-IM-21
22Saussurea lappa (L.)CompositaeKuthRoot ZD-IM-22
23Sisymbrium irio (L.)BrassicaceaeLondon rocketSeeds ZD-IM-23
24Syzygium cumini (L.)MyrtaceaeJambolan Fruit, leavesZD-IM-24
25Thymus vulgaris (L.)LamiaceaeThymeLeavesZD-IM-25
26Viola odorata (L.)ViolaceaeSweet violetLeaves, flowers ZD-IM-26
27Vitis vinifera (L.)Vitaceae GrapesLeaves, fruits ZD-IM-27
28Zingiber officinale (Roscoe)ZingiberaceaeGingerRoot ZD-IM-28
29Ziziphus jujuba (mill.)RhamnaceaeRed dateFruit ZD-IM-29

The plants materials were dried in shades, identified by the help of Dr. Muhammad Nasir (Taxonomist, Department of Botany, University of the Punjab), and kept in Microbiology and Immunology Laboratory (Department of Zoology, University of the Punjab) under the voucher numbers listed above.
2.2. Bacterial Strains

Methicillin-resistant and methicillin-susceptible S. aureus and Pseudomonas aeruginosa (P. aeruginosa) strains were isolated from sore throat patients from tertiary care hospitals at Faisalabad. ATCC strains of Escherichia coli (E. coli) and S. aureus were obtained from lab stock. All strains were routinely grown and identified. For further use they were preserved at −20°C.

2.3. Antimicrobial Susceptibility of Clinical Isolates

Antibiotic sensitivity of the isolated S. aureus strains was determined by Standard Disc Diffusion Method [19]. Different antibiotics (Oxoid) were used in the present work: tetracycline (30 μg), vancomycin (30 μg), clindamycin (2 μg), methicillin (5 μg), cefixime (5 μg), erythromycin (15 μg), oxacillin (1 μg), gentamicin (10 μg), streptomycin (10 μg), chloramphenicol (30 μg), linezolid (10 μg), ampicillin-sulbactam (20 μg), and penicillin (10 μg) [20].

2.4. Minimum Inhibitory Concentration (MIC)

Minimum inhibitory concentrations (MIC) of antibiotics and plant extracts were determined by the microdilution method as described by Clinical and Laboratory Standards Institute (formerly the National Committee for Clinical Laboratory Standards, NCCLS) [20]. The antibiotic was serially diluted in Mueller-Hinton broth in 96-well plates. The plant extracts solutions were separately added to wells in a final concentration of 1 mg/mL; then bacterial inoculum size of 105 CFU/mL was added to each well. Controls without plant extracts, without bacterial inoculum, or with plant extracts only were also included in the experiment. Each plant extract was run in duplicate. The test plates were incubated at 37°C for 24 h. The MIC was taken as the minimum concentration of the dilutions that inhibited the growth of the test microorganism. The growth was recorded in terms of button formation in wells; it was confirmed by adding tetrazolium chloride.

2.5. Toxicity of Extracts to Human Erythrocytes

The cellular toxicity of the extracts from different plants was determined [21]. Erythrocytes were isolated from human blood by removing plasma and buffy coat and suspended in phosphate buffered saline (10 mM phosphate, 150 mM sodium chloride) making a final concentration of 2% erythrocytes. The dilutions of plant extract (100 mg/mL) were made and mixed with erythrocytes keeping the final volume up to 1 mL. The cells were incubated for 1 hr at 37°C and finally centrifuged at 1500 rpm for 10 minutes [22]. The lysis of the cells was observed by determining absorbance at 540 nm using spectrometer. Cell in distilled water was taken as negative and cells suspended in normal saline were taken as positive control. The mixture was centrifuged at 1500 rpm for 1 minute in a laboratory centrifuge. The free haemoglobin in the supernatant was measured at 540 nm.

The haemolysis percentage was calculated by the following formula: At is absorbance of test sample, An is absorbance of the control (saline), and Ac is absorbance of the control (water).

2.6. Screening and Estimation of Some Phytochemical Components

Phytochemical screening of the effective extract for the detection of alkaloids, flavonoids, steroids, terpenoid, and other secondary metabolites was carried out by following the procedure of Trease and Evans [23]. Total alkaloids, flavonoids, and saponin fraction were also separated and their antimicrobial activity was carried out [24].

2.7. Thin Layer Chromatography, Bioautography, and Identification of the Chemical Nature of the Bioactive Compound

For TLC, 10–20 μL of plant extract was loaded on silica gel sheet (Merck, Darmstadt, Germany). Different solvent systems, chloroform : methanol (80 : 20), n-butanol : acetic acid : water (4 : 1 : 1), and acetone : methanol (1 : 1), were used as mobile phase. The TLC plates (a–f) were run in triplicate. Plate “a” was used to determine the spots by visualizing in UV light to see if the separated spot was UV active after which it was sprayed with vanillin sulphuric acid reagent (2%) to detect all the separated spots. Plate “b” was used for autobiography. Agar overlay method [25] was used for direct bioautographic assay, with little modification, to detect antimicrobial fractions in plant extracts which were active against clinical sample of MRSA and E. coli. Soft nutrient agar (1%) was seeded with 106 CFU/mL of MRSA/E. coli and overlaid on TLC plate. It was then incubated overnight in a controlled environment at 37°C. Subsequently, the plates were sprayed with 2,3,5-triphenyltetrazolium chloride and further incubated for three hours at 37°C. Microbial growth inhibition appeared as clear zone against a pink background. The Rf value of the bioactive spots was measured as the ratio of mobility of centre of a bioactive spot against the total distance travelled by the solvent front. The bioactive spots were scraped from the TLC plate “c” and eluted in 500 μL ethanol. The solution was filtered using Whatman filter paper number 1 and concentrated and again bioassay was performed to recheck the activity. Plates “d, e, and f” were sprayed separately with TLC reagents including FeCl3 (10%), Dragendorff’s reagent, and KOH (5N) to detect the presence of phenolic compounds, alkaloids, and flavonoids, respectively, in bioactive spots.

3. Results

3.1. Antibiotic Susceptibility and Responses to Plant Extracts

All clinical isolates and ATCC E. coli were resistant to beta-lactam group, whereas ATCC 25923 was sensitive to all antibiotics used in the study. The clinical isolates were also resistant to diverse groups of antibiotics (Table 2). Aqueous and n-hexane extracts displayed antimicrobial activity with ZI < 11 mm, while methanolic extracts of 18/29 plants were found to be active and showed varying activity with a zone of inhibition of 11–25 mm for all the clinical and reference strains. The MIC of the extracts ranged from 3.90 to 250 μg/mL (Table 3).

Clinical sampleResistantIntermediateSensitive

S1Me, cef, eryth, oxa, strep, amp, penNoTet, vanco, clind, genta, chlo, lin
S2Tet, clin, me, cef, ery, oxa, chlo, amp, penNoneVan, gen, strep, lin
S3Tet, me, cef, oxa, gen, penNoneVan, clin, ery, strep, chlo, lin, amp
P. aeruginosa me, cef, oxa, gen, pen, eryTet, clin, ampVan, clin, strep, chlo, lin
E. coli ATCC 8739Me, penNoneTet, cef, oxa, gen, Van, clin, ery, strep, chlo, lin, amp
S. aureus ATCC 25923NoneNoneTet, me, cef, oxa, gen, pen, Van, clin, ery, strep, chlo, lin, amp

Serial number Plant nameS1S2S3P. aeruginosaS. aureus (25293)E. coli (8739)

1Adhatoda vasica1731.251831.252131.251962.5217.811831.25
2Althaea officinalis1631.251831.252031.252031.252015.632031.25
3Cinnamomum zeylanicum2025022125257.81201252512522250
4Cordia latifolia1631.251862.52031.25171252012.631962.50
5Emblica officinalis111251225013125131251362.5012250
6Glycyrrhiza glabra1812520250221251762.502231.2519125
7Hyssopus officinalis1812519250221251831.252231.251862.50
8Lawsonia inermis122501325015250141251512513250
9Linum usitatissimum212502225022250191252212520250
10Malva sylvestris1512516250181251562.51862.5016125
11Matricaria chamomilla1212513250141251362.51362.5015125
12Moringa oleifera1325014500152501562.51562.5014250
13Morus alba131251225013125131251331.2513125
14Origanum vulgare227.812015.62227.81207.81223.912115.63
15Sisymbrium irio2012522250251252162.52562.5020125
16Syzygium cumini1362.5131251562.501331.251515.631362.50
17Thymus vulgaris2215.632231.252515.63227.81257.812131.25
18Ziziphus jujuba1415.631431.251215.63217.81147.811631.25

3.2. Phytochemical Analysis

The plant extracts which showed promising antimicrobial activity were investigated further for the presence of flavonoids, terpenoids, steroids, and glycosides, and other phytochemicals results are given in Table 4. Alkaloids, flavonoids, and saponin fraction were separated. MIC and their bioactivity were checked out (Table 5). Alkaloids fraction of Adhatoda vasica, Cordia latifolia, and Origanum vulgare and flavonoid fraction of Althaea officinalis, Origanum vulgare, Thymus vulgaris, and Ziziphus jujuba displayed antimicrobial activity against MRSA. MIC of the alkaloids and flavonoids ranged from 3.25 to 12.5 (μg/mL) and zone of inhibition ranged from 13 to 18 mm.

Serial numberPlant nameYield
Alk.Flv.Ter.Ste.Sap.Tan.Carb.Pro.Car. Gly.Phe.Red. Sug.

1Adhatoda vasica18.2+++++++++
2Althaea officinalis22++++++++++++++
3Cordia latifolia29.9+++++++
4Origanum vulgare35.6++++++++
5Thymus vulgaris22.9+++
6Ziziphus jujuba22.5++++++

Tan., tannins; Alk., alkaloids; Flv., flavonoids; Ter., terpenoids; Ste., steroids; Sap., saponins; Carb., carbohydrate; Pro., proteins; Car. Gly., cardiac glycosides; Phe., phenols; Red. Sug., reducing sugar.
++: high concentration.
: absence.

Serial number Plant nameAlkaloidFlavonoidSaponin
ZI (mm)MIC (µg/mL)% age estimationZI (mm)MIC (µg/mL)% age estimationZI (mm)MIC (µg/mL)% age estimation

1Adhatoda vasica136.2520>1000>100
2Althaea officinalisN.DN.D1412.51.030>1002.7
3Cordia latifolia1412.50.80N.D0N.D
4Origanum vulgare186.251.5153.252.5N.D
5Thymus vulgarisN.D166.252.3N.D
6Ziziphus jujubaN.D136.251.33N.D

N.D: activity not determined.
3.3. Thin Layer Chromatography and Autobiography

Different solvent systems comprising water, methanol, acetic acid, chloroform, n-butanol, toluene, ethyl acetate, and formic acid in different combination were used to separate the active part. The best solvent systems were chloroform and methanol (80 : 20), n-butanol, acetic acid, and water (4 : 1 : 1). Active parts of all the plant extract were not separated in a single solvent system which gives us the information that the active fractions vary in their chemical nature. Antimicrobial fractions of the crude extract were separated by TLC followed by autobiography method. The Rf value of active fraction is shown in Table 6. When TLC plate was visualized under UV different coloured spots were seen and marked and their antimicrobial activity was checked out. The chemical nature of the antimicrobial compound was detected by spraying with Dragendorff’s reagent for alkaloids and 10% FeCl3 for phenolic compound and 5N KOH solution for flavonoids.

Serial numberPlant nameRf value
Mobile phase

1Adhatoda vasica0.4 (alkaloids)
Chloroform : methanol (80 : 20)

2Ziziphus jujuba0.15 (phenol)
0.18 (flavonoids)
0.65 (phenol)
0.71 (phenol)
Chloroform : methanol (80 : 20)

3Althaea officinalis0.72
0.45 (flavonoids)
Chloroform : methanol (80 : 20)

4Cordia latifolia0.67
0.84 (alkaloids)
Acetone : methanol (1 : 1)

5Origanum vulgare0.75
0.79 (flavonoids)
0.82 (alkaloids)
Butanol : acetic acid : water (4 : 1 : 1)

6Thymus vulgaris0.72 (phenol)
Butanol : acetic acid : water (4 : 1 : 1)

Retention factor.

Thin layer chromatography plates after the development show various components in light and when visualized under UV other parts were also visualized. Direct autobiography on TLC plates revealed presence of active antimicrobial components in all six plants with different Rf values (Table 6).

3.4. Haemolysis Percentage of the Crude Methanolic Extract

In vitro evaluation of the toxicity of the extract by comparing the haemolysis percentages is shown in Figure 1. It has been shown in the graph that the maximum haemolytic activity was shown by methanolic extract of the Cordia latifolia and the minimum haemolytic activity was shown by Origanum vulgare. On the basis of haemolytic potential the selected plants could be arranged as follows: Cordia latifolia > Ziziphus jujuba > Althaea officinalis Adhatoda vasica > Thymus vulgaris > Origanum vulgare.

4. Discussion

The interest in research on medicinal plants has increased over the last few decades due to the emergence of MDR strains of important pathogens like S. aureus, P. aeruginosa, and E. coli [26]. Some of the antibiotics against which resistance has been developed include penicillin G, macrolides, lincosamides, tetracycline, and gentamicin [27]. Investigations are needed for antibacterial agents that offer broad-spectrum activity against resistant strains of microorganisms. Toxicity profiling of the plant extract also needs scientific validation.

In the present study, twenty-nine plants that were recommended by herbal practitioners for treatment of diseases related to respiratory tract were evaluated for their antibacterial activity against MDR strains of S. aureus, E. coli, and P. aeruginosa isolated from sore throat patients. Although the antibacterial effect of these plants has already been reported by many workers, their activities against MDR strains are less evaluated [2831]. Moreover, the current study focused on the phytochemical nature of active fraction. Three types of extracts, n-hexane, water, and methanol, were tested for their possible antibacterial activity against ATCC bacterial cultures of Gram-positive and Gram-negative bacteria and clinical samples of MDR S. aureus and P. aeruginosa isolated from the sore throat patients. A zone of inhibition of >11 mm was considered as a standard for effectiveness of extract against bacteria. The n-hexane extracts did not show any zone of inhibition, while aqueous extract inhibits microbial growth with a zone of inhibition of less than 11 mm. Although the aqueous extract preparation mimics the traditional method of use, very little antimicrobial activity was observed in it, which might be due to less solubility of active components in water [32, 33]. On the other hand methanolic extract of 18/29 plants exhibits ZI > 11 mm and MIC of 3.91–500 μg/mL, indicating that methanolic extract contains a variety and better quantity of bioactive compounds. Such observation has also been noticed by some workers [34, 35].

Plants extracts having MIC ≤ 100 μg/mL against all test strains were selected for detailed study including phytochemical analysis (qualitative and quantitative), TLC, autobiography, and in vitro toxicity. Qualitative analysis revealed the presence of alkaloids, flavonoids, terpenoids, steroids, saponin, tannins, carbohydrates, proteins, cardiac glycosides, phenols, and reducing sugars. The saponin, alkaloids, and flavonoids are documented as the most active ingredients to which the antimicrobial activities of many plant species can be attributed [36]. Therefore, quantitative analysis was carried out for these. Moreover, their rich fractions were verified to be responsible for antibacterial activity against test strains.

Adhatoda vasica contained bioactive alkaloid (2%) fraction. On TLC plates, three spots were noticed by bioautography which separated at 0.4, 0.86, and 0.92 Rf values in chloroform : methanol (80 : 20) solvent system. One of the spots was identified as alkaloid, while chemical nature of other 2 spots could not be determined. Adhatoda vasica has also been recognized for its diverse health benefits along with antimicrobial potential. Kaur et al. [37] and Sawant et al. [38] have recently reported antimicrobial activity against respiratory pathogens S. aureus and E. coli. The differences may be due to strain specificity or geographical variations in plant spp. Alkaloids l-vasicinone, deoxyvasicine, maiontone, vasicinolone, and vasicinol were reported in Adhatoda vasica by Jain and Sharma [39]. The current study indicates that it is not only alkaloid that shows antimicrobial activity; some other compounds of different nature are also bioactive and further studies are required for their separation and identification.

Origanum vulgare contained bioactive alkaloid (1.5%) and flavonoid (2.5%) fraction. On TLC plates, three spots were noticed by following autobiography which separated at Rf 0.75, 0.79, and 0.82 values in butanol : acetic acid : water (4 : 1 : 1) solvent system. One of the spots with Rf value of 0.79 was identified as alkaloid and another one with Rf value of 0.82 was identified as flavonoid, while chemical nature of the third spot could not be determined. Origanum vulgare and its EO have also been recognized for its antimicrobial and antioxidant nature [40]. The current study indicates that alkaloid and flavonoids as well as other compounds with antimicrobial potential can be purified from Origanum vulgare and used against MDR.

Thymus vulgaris leaves and essential oil are used in cosmetic and food additives [41, 42]. Antimicrobial potential of thymus was also reported [43, 44], but nature of component was not known. In this study, phenolic compound with Rf value of 0.72 was found responsible for antibiotic activity, while another of unknown nature was also bioactive.

Flavonoid of Ziziphus displayed antimicrobial activity. Recently published data on antimicrobial properties against Gram-positive and Gram-negative pathogenic bacteria have been reported [45], whereas the presence of alkaloids, flavonoids, and saponin in Ziziphus jujuba extracts was reported by [46]. The current study confirms antimicrobial nature of its flavonoid. TLC plate separation leads to identification of 5 spots with bioautography of Rf value of 0.15, 0.18, 0.65, 0.71, and 0.85 through autobiography. Among them 3 were phenolic; one of them was flavonoid, whereas chemical nature of one spot with Rf of 0.85 remained unclear. The current study indicates that the flavonoids with Rf of 0.45 and one compound with Rf of 0.72 have this activity. In a review presence of a variety of flavonoids in the methanolic extract was reported by Gao et al. [47].

TLC separation of methanolic extract of Cordia latifolia showed 03 bioactive spots with Rf value of 0.84, 0.67, and 0.35. The alkaloid fraction of the methanolic extract with Rf value of 0.84 and other two spots with Rf value of 0.67 and 0.35 of unknown nature show antibacterial activity.

Scientific validations of the safety of extracts are mandatory for recommendation to human. The erythrocyte haemolysis has been widely used as an indicator of toxicity of injectable formulations as well as a general indication of membrane toxicity. Haemolysis is due to red blood cells destruction which resulted from lysis of membrane lipid bilayer. This haemolysis relates to concentration and chemical composition of extract. Data about the safety of Cordia latifolia and Althaea officinalis has been provided by May and Willuhn [48] and Caparroz-Assef et al. [49]. Extracts of Adhatoda vasica, Althaea officinalis, Oregano vulgaris, Cordia latifolia, Althaea officinalis, and Thymus vulgaris were used in toxicity study and revealed 0.93–6.48% haemolytic activity and are found to be safe for human use.

5. Conclusion

In conclusion 29 plants included in the study were already known for their antimicrobial nature; the current study found that 18/29 possess these characteristics against MDR strains and 6/18 are good candidates for isolation of effective components. Cordia latifolia, Ziziphus jujuba, Althaea officinalis, Adhatoda vasica, Thymus vulgaris, and Origanum vulgare have good antimicrobial activity and their haemolysis assay declared them safe candidate for the treatment of sore throat in human. Alkaloids of Adhatoda vasica, Cordia latifolia, and Origanum vulgare and flavonoids of Althaea officinalis, Origanum vulgare, Thymus vulgaris, and Ziziphus jujuba may be utilized for the treatment of MRSA.

Competing Interests

The authors declare that they have no competing interests.


  1. C. J. L. Murray and A. D. Lopez, “Global mortality, disability, and the contribution of risk factors: global burden of disease study,” The Lancet, vol. 349, no. 9063, pp. 1436–1442, 1997. View at: Publisher Site | Google Scholar
  2. J. Fry, Common Diseases—Their Nature, Incidence and Care, MTP Press, Lancaster, Pa, USA, 2nd edition, 1979.
  3. J. Kluytmans, A. Van Belkum, and H. Verbrugh, “Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks,” Clinical Microbiology Reviews, vol. 10, no. 3, pp. 505–520, 1997. View at: Google Scholar
  4. R. P. Wenzel and T. M. Perl, “The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection,” Journal of Hospital Infection, vol. 31, no. 1, pp. 13–24, 1995. View at: Publisher Site | Google Scholar
  5. H. F. L. Wertheim, M. C. Vos, A. Ott et al., “Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers,” The Lancet, vol. 364, no. 9435, pp. 703–705, 2004. View at: Publisher Site | Google Scholar
  6. S. Pyörälä and S. Taponen, “Coagulase-negative staphylococci-emerging mastitis pathogens,” Veterinary Microbiology, vol. 134, no. 1-2, pp. 3–8, 2009. View at: Publisher Site | Google Scholar
  7. A. Norrby-Teglund, M. P. Muller, A. McGeer et al., “Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach,” Scandinavian Journal of Infectious Diseases, vol. 37, no. 3, pp. 166–172, 2005. View at: Publisher Site | Google Scholar
  8. S. Bronzwaer, U. Buchholz, P. Courvalin et al., “Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European antimicrobial resistance surveillance system (EARSS) in collaboration with the United Kingdom national external quality assurance scheme (UK NEQAS),” The Journal of Antimicrobial Chemotherapy, vol. 50, no. 6, pp. 953–964, 2002. View at: Publisher Site | Google Scholar
  9. A. Farooqui, Studies on the antimicrobial and immunomodulating properties of plant extracts on bacterial pathogens [Ph.D. thesis], Department of Microbiology, Faculty of Science, University of Karachi, Karachi, Pakistan, 2008.
  10. K. C. Eseonu, S. D. Middleton, and C. C. Eseonu, “A retrospective study of risk factors for poor outcomes in methicillin-resistant staphylococcus aureus (MRSA) infection in surgical patients,” Journal of Orthopaedic Surgery and Research, vol. 6, no. 1, article 25, 2011. View at: Publisher Site | Google Scholar
  11. F. B. S. Bazzaz, M. Khajehkaramadin, and H. R. Shokooheizadeh, “In vitro antibacterial activity of Rheum ribes extract obtained from various plant parts against clinical isolates of Gram-negative pathogens,” Journal of Pharmaceutical Research, vol. 2, pp. 87–91, 2005. View at: Google Scholar
  12. B. E. Abu-Irmaileh and F. U. Afifi, “Herbal medicine in Jordan with special emphasis on commonly used herbs,” Journal of Ethnopharmacology, vol. 89, no. 2-3, pp. 193–197, 2003. View at: Publisher Site | Google Scholar
  13. WHO, WHO Traditional Medicine Strategy, WHO, Geneva, Switzerland, 2002.
  14. S. P. Fernandez, N. Karim, K. N. Mewett, M. Chebib, G. A. R. Johnston, and J. R. Hanrahan, “Flavan-3-ol esters: new agents for exploring modulatory sites on GABAA receptors,” British Journal of Pharmacology, vol. 165, no. 4, pp. 965–977, 2012. View at: Publisher Site | Google Scholar
  15. G. Tegos, F. R. Stermitz, O. Lomovskaya, and K. Lewis, “Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 10, pp. 3133–3141, 2002. View at: Publisher Site | Google Scholar
  16. A. Marston, “Thin-layer chromatography with biological detection in phytochemistry,” Journal of Chromatography A, vol. 1218, no. 19, pp. 2676–2683, 2011. View at: Publisher Site | Google Scholar
  17. C. F. Poole, “Thin-layer chromatography: challenges and opportunities,” Journal of Chromatography A, vol. 1000, no. 1-2, pp. 963–984, 2003. View at: Publisher Site | Google Scholar
  18. Á. M. Móricz, N. Adányi, E. Horváth, P. G. Ott, and E. Tyihák, “Applicability of the BioArena system to investigation of the mechanisms of biological effects,” Journal of Planar Chromatography—Modern TLC, vol. 21, no. 6, pp. 417–422, 2008. View at: Publisher Site | Google Scholar
  19. A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966. View at: Google Scholar
  20. National Committee for Clinical Laboratory Standards (NCCLS), “Methods for dilution antimicobial susceptibility tests for bacteria that grows aerobically,” Approved Standards M7-A4, National Committee for Clinical Laboratory Standards (NCCLS), Wayne, Pa, USA, 1997. View at: Google Scholar
  21. X.-G. He, U. Mocek, H. G. Floss et al., “An antifungal compound from Solanum nigrescens,” Journal of Ethnopharmacology, vol. 43, no. 3, pp. 173–177, 1994. View at: Publisher Site | Google Scholar
  22. S. Safiuddin, Unani Advia Mufrida, National Council for Urdu, Ministry of Human Resources and Development, Government of India, New Delhi, India, 8th edition, 1999.
  23. G. Trease and W. Evans, Pharmacognosy, Saunders, London, UK, 2002.
  24. D. Krishnaiah, T. Devi, A. Bono, and R. Sarbatly, “Studies on phytochemical constituents of six Malaysian medicinal plants,” Journal of Medicinal Plants Research, vol. 3, no. 2, pp. 067–072, 2009. View at: Google Scholar
  25. A. J. Slusarenko, A. C. Longland, and I. M. Whitehead, “A convenient, sensitive and rapid assay for antibacterial activity of phytoalexins,” Botanica Helvetica, vol. 99, pp. 203–207, 1989. View at: Google Scholar
  26. A. E. Osbourn, “Preformed antimicrobial compounds and plant defense against fungal attack,” The Plant Cell, vol. 8, no. 10, pp. 1821–1831, 1996. View at: Publisher Site | Google Scholar
  27. G. A. J. Ayliffe, “The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus,” Clinical Infectious Diseases, vol. 24, supplement 1, pp. S74–S79, 1997. View at: Publisher Site | Google Scholar
  28. S. Saeed and P. Tariq, “Antibacterial activity of oregano (Origanum vulgare Linn.) against gram positive bacteria,” Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 4, pp. 421–424, 2009. View at: Google Scholar
  29. S. Moradi, S. H. Razavi, and A. Vasiee, “Antioxidant and antimicrobial activity of Thymus vulgaris L. on some pathogenic bacteria ‘in vitro’,” Agricultural Advances, vol. 3, no. 4, pp. 124–130, 2014. View at: Google Scholar
  30. S. S. Gautam, Navneet, S. Kumar, and R. Chauhan, “Antimicrobial efficacy of Althaea officinalis Linn. seed extracts and essential oil against respiratory tract pathogens,” Journal of Applied Pharmaceutical Science, vol. 5, no. 9, pp. 115–119, 2015. View at: Publisher Site | Google Scholar
  31. C. Walter, Z. K. Shinwari, I. Afzal, and R. Malik, “Antibacterial activity in herbal products used In Pakistan,” Pakistan Journal of Botany, vol. 43, pp. 155–162, 2011. View at: Google Scholar
  32. A. C. Kariuki and G. N. Njoroge, “Ethnobotanical and antimicrobial studies of some plants used in kibwezi (Kenya) for management of lower respiratory tract infections,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 8, no. 2, pp. 144–149, 2011. View at: Google Scholar
  33. S. F. van Vuuren and D. Naidoo, “An antimicrobial investigation of plants used traditionally in Southern Africa to treat sexually transmitted infections,” Journal of Ethnopharmacology, vol. 130, no. 3, pp. 552–558, 2010. View at: Publisher Site | Google Scholar
  34. S. Ozturk and S. Ercisli, “Antibacterial activity and chemical constitutions of Ziziphora clinopodioides,” Food Control, vol. 18, no. 5, pp. 535–540, 2007. View at: Publisher Site | Google Scholar
  35. Y. L. Ramachandra, C. Ashajyothi, and P. Rai, “In Vitro antibacterial Potential of Boerhaavia diffusa,” International Journal of Advances in Pharmacy, Biology and Chemistry, vol. 1, no. 3, pp. 420–424, 2012. View at: Google Scholar
  36. E. M. Bartels, J. Swaddling, and A. P. Harrison, “An ancient Greek pain remedy for athletes,” Pain Practice, vol. 6, no. 3, pp. 212–218, 2006. View at: Publisher Site | Google Scholar
  37. I. Kaur, P. K. Chauhan, M. Jaryal, S. Saxena, and Kanisha, “Antioxidant and antimicrobial activity of leaf extract of Adhatoda vasica against the bacteria isolated from the sputum samples of asthmatic patients,” International Journal of Drug Research and Technology, vol. 2, no. 3, pp. 273–278, 2012. View at: Google Scholar
  38. C. S. Sawant, S. S. Save, and A. M. Bhagwat, “Antimicrobial activity of alkaloids extracted from Adhatoda vasica,” International Journal of Pharma and Bio Sciences, vol. 4, no. 3, pp. B803–B807, 2013. View at: Google Scholar
  39. M. P. Jain and V. K. Sharma, “Phytochemical investigation of roots of Adhatoda vasica,” Planta Medica, vol. 46, no. 4, article 250, 1982. View at: Publisher Site | Google Scholar
  40. M. Moradi, A. Hassani, A. Ehsani, M. Hashemi, M. Raeisi, and S. S. Naghibi, “Phytochemical and antibacterial properties of Origanum vulgare ssp. gracile Growing Wild in Kurdistan Province of Iran,” Journal of Food Quality and Hazards Control, vol. 1, pp. 120–124, 2014. View at: Google Scholar
  41. J. E. Simon, M. R. Morales, W. B. Phippen, R. F. Vieira, and Z. Hao, “A source of aroma compounds and a popular culinary and ornamental herb,” in Perspectives on New Crops and New Uses, J. Janick, Ed., pp. 499–505, ASHS Press, 1999. View at: Google Scholar
  42. F. Senatore, “Influence of harvesting time on yield and composition of the essential oil of a thyme (Thymus pulegioides L.) growing wild in Campania (Southern Italy),” Journal of Agricultural and Food Chemistry, vol. 44, no. 5, pp. 1327–1332, 1996. View at: Publisher Site | Google Scholar
  43. G. G. F. Nascimento, J. Locatelli, P. C. Freitas, and G. L. Silva, “Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria,” Brazilian Journal of Microbiology, vol. 31, no. 4, pp. 247–256, 2000. View at: Publisher Site | Google Scholar
  44. F. Benbelaid, M. A. Abdoune, A. Khadir, and M. Bendahou, “Drying effect on the yield and antimicrobial activity of essential oils,” International Journal of Medicinal and Aromatic Plants, vol. 3, no. 1, pp. 93–101, 2013. View at: Google Scholar
  45. B. Ahmad, I. Khan, S. Bashir, S. Azam, and F. Hussain, “Screening of Zizyphus jujuba for antibacterial, phytotoxic and haemagglutination activities,” African Journal of Biotechnology, vol. 10, no. 13, pp. 2514–2519, 2011. View at: Google Scholar
  46. S. H. Abd-Alrahman, M. S. Mounir, A. M. E. Elhalwagy, and M. A. Wael, “Phytochemical screening and antimicrobial activity of EthOH/water Ziziphus jujuba seeds extracts,” Journal of Pure and Applied Microbiology, vol. 7, pp. 823–828, 2013. View at: Google Scholar
  47. Q.-H. Gao, C.-S. Wu, and M. Wang, “The Jujube (Ziziphus Jujuba Mill.) fruit: a review of current knowledge of fruit composition and health benefits,” Journal of Agricultural and Food Chemistry, vol. 61, no. 14, pp. 3351–3363, 2013. View at: Publisher Site | Google Scholar
  48. G. May and G. Willuhn, “Antiviral activity of aqueous extracts from medicinal plants in tissue cultures,” Arzneimittel-Forschung, vol. 28, no. 1, pp. 1–7, 1978. View at: Google Scholar
  49. S. M. Caparroz-Assef, R. Grespan, R. C. Freire Batista et al., “Toxicity studies of Cordia salicifolia extract,” Acta Scientiarum—Health Sciences, vol. 27, no. 1, pp. 41–44, 2005. View at: Google Scholar

Copyright © 2016 Arifa Mehreen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2942 Views | 1602 Downloads | 13 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.